Øyvind Arnesen • 1957 • Skedsmokorset • 8 roles • 1 shareholding

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
V VITMED AS	Managing Director/CEO	1,349,334	3,622,800	100 % directly
H HUBRO THERAPEUTICS AS	Managing Director/CEO	-	36,467,975	-

Boards

Name	Role	Total operating income	Total equity	Shares
V VITMED AS	Chairman	1,349,334	3,622,800	100 % directly
C CYTOVATION ASA	Board Member	-	-30,436,620	-
O OSLO CANCER CLUSTER SA	Chairman	18,655,000	28,521,000	-
H HUBRO THERAPEUTICS AS	Chairman	-	36,467,975	-
R RAB DIAGNOSTICS AS	Chairman	-	21,760	-
A ADJUTEC PHARMA AS	Chairman	7,333,247	18,067,485	-

Last update: Mar 2, 2024

Related industries1

Professional, scientific and technical activities

Direct relationships5

KW
Ketil Forsland Widerberg1977
OSLO CANCER CLUSTER SA
OJ
Ole Jesper Dahlberg1971
RAB DIAGNOSTICS AS
NW
Nicolaj Refshall Weiergang1974
ADJUTEC PHARMA AS
AK
Alf Kristian Berg1955
RAB DIAGNOSTICS AS
PM
Per Morten Sandset1956
OSLO CANCER CLUSTER SA

Shares owned by Øyvind Kongstun Arnesen

Name	Share class	Total operating income	Total equity	Share
V VITMED AS	Ordinære aksjer	1,349,334	3,622,800	100 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024